<DOC>
	<DOC>NCT00983801</DOC>
	<brief_summary>The purpose of this study was to determine whether ixabepilone is effective in the treatment of unresectable or metastatic gastric cancer in Asian participants.</brief_summary>
	<brief_title>Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<criteria>Histologically confirmed gastric carcinoma originating from the stomach or gastroesophageal junction Must have unresectable or metastatic disease Asian ethnicity Must have failed prior fluoropyrimidinebased chemotherapy Eastern Cooperative Oncology Group (ECOG) performance status of 01 measurable disease by with Response Evaluation Criteria in Solid Tumors (RECIST) guidelines &gt;1 prior chemotherapy regimen in the metastatic setting or &gt;2 prior chemotherapy if subject also received adjuvant therapy Receipt of prior ixabepilone ECOG ≥2 Known brain or meningeal metastasis Known viral hepatitis Prior taxane therapy Uncontrolled noncancer related medical condition Second malignancy Peripheral neuropathy ≥ grade 2 Inadequate hematologic, renal and hepatic function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>